Stuart K. Williams
Technik-/Wissenschafts-/F&E-Leiter bei Koligo Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Matthew B. Lehman | M | 47 |
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia.
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | - |
| Mike Hughes | M | - |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | - |
| Balamurugan N. Appakalai | M | - |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | - |
| Brian Lavin | M | - |
University of Louisville
| - |
| Robert Lewis Taylor | M | 84 |
University of Louisville
| - |
| Mahendra Kumar Sunkara | M | 59 |
University of Louisville
| - |
| Jean Bandos | F | - |
University of Louisville
| - |
| James C. Seiffert | M | - |
University of Louisville
| 21 Jahre |
| Donald Miller | M | - |
University of Louisville
| - |
| Adel S. Elmaghraby | M | - |
University of Louisville
| - |
| Terry L. Singer | M | - |
University of Louisville
| - |
| Mark Slaughter | M | - |
University of Louisville
| - |
| Michael J. Curtin | M | - |
University of Louisville
| 39 Jahre |
| Ron Butt | M | - |
University of Louisville
| - |
| Norman D. Radtke | M | - |
University of Louisville
| - |
| Gustavo A. Perez-Abadia | M | - |
University of Louisville
| - |
| Albert R. Cunningham | M | - |
University of Louisville
| - |
| Roland Valdes | M | - |
University of Louisville
| - |
| Herbert W. Perkins | M | - |
University of Louisville
| - |
| Robert D. Dowling | M | - |
University of Louisville
| - |
| Roderick D. Purdy | M | - |
University of Louisville
| - |
| Jason Tomlinson | M | - |
University of Louisville
| - |
| Robert Clisdell | M | - |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
| Jethro Marks | M | - |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
| John Karman | M | - |
University of Louisville
| - |
| Ellsworth Collins | M | - |
University of Louisville
| - |
| David Potash | M | - |
University of Louisville
| - |
| John F. Naber | M | - |
University of Louisville
| - |
| Dale J. Boden | M | 67 |
University of Louisville
| - |
| J. McCauley Brown | M | 71 |
University of Louisville
| - |
| Kelly M. McMasters | M | 63 |
University of Louisville
| 28 Jahre |
| Roger W. Schipke | M | 87 |
University of Louisville
| 22 Jahre |
| Stanley A. Gall | M | - |
University of Louisville
| - |
| Sandra Metts Snowden | F | 78 |
University of Louisville
| - |
| Robert D. Nixon | M | 73 |
University of Louisville
| - |
| Andrew Bursill | M | 53 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
| Peter James | M | 74 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
| Wendy C. Welsh | F | 70 |
University of Louisville
| - |
| George R. Siemens | M | 74 |
University of Louisville
| - |
| Ricky May | M | - |
University of Louisville
| 40 Jahre |
| William P. Hnat | M | - |
University of Louisville
| - |
| James P. Dailey | M | - |
University of Louisville
| - |
| James Sublett | M | - |
University of Louisville
| - |
| Fred J. Roisen | M | - |
University of Louisville
| 38 Jahre |
| Haval Shirwan | M | - |
University of Louisville
| - |
| Dana Bowers | F | - |
University of Louisville
| - |
| Steven T. Hester | M | - |
University of Louisville
| - |
| Stephen J. Pollard | M | - |
University of Louisville
| - |
| Christopher Brennan | M | 68 |
University of Louisville
| - |
| Sharon Moore | M | - |
University of Louisville
| - |
| Larry N. Cook | M | - |
University of Louisville
| - |
| Angela Curry | F | 51 |
University of Louisville
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 48 | 92,31% |
| Australien | 5 | 9,62% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stuart K. Williams
- Persönliches Netzwerk